Chenxin Pharmaceutical: Shareholder Han Yanzhen plans to reduce his stake in the company by no more than 3%.

Chenxin Pharmaceutical announced that shareholder Han Yanzhen, who holds more than 5% of the shares, plans to reduce his holdings by no more than 4.53 million shares through centralized bidding trading within 3 months after the announcement is disclosed for 15 consecutive trading days, not exceeding 1% of the total share capital of the company; reducing holdings by no more than 9.06 million shares through block trading, not exceeding 2% of the total share capital of the company, for a total reduction of no more than 13.58 million shares, not exceeding 3% of the total share capital of the company. The divestment plan is based on the shareholder's own financial needs and will not have a significant impact on the company's governance structure and ongoing operations.